# Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

> **NCT05236049** · PHASE1 · COMPLETED · sponsor: **TBF Genie Tissulaire** · enrollment: 12 (actual)

## Conditions studied

- Enucleated; Eye
- Eye Cancer

## Interventions

- **BIOLOGICAL:** SclerFIX

## Key facts

- **NCT ID:** NCT05236049
- **Lead sponsor:** TBF Genie Tissulaire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-04-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236049, "Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05236049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*